Suchergebnisse - "Vermeire, S"

PubPharm (12)

1

Letter : vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease-authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Mahadevan, U. | Vermeire, S. | Lasch, K. | +4

CommentOn: Aliment Pharmacol Ther. 2017 Apr;45(7):941-950. - PMID 28169436

2

Editorial : vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2017

von Mahadevan, U. | Vermeire, S. | Lasch, K. | +4

CommentOn: Aliment Pharmacol Ther. 2017 Apr;45(7):941-950. - PMID 28169436

3

Letter : detection of infliximab levels and anti-infliximab antibodies--comparison of three different assays; authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2013

von Buurman, D. | Vande Casteele, N. | Sturkenboom, M. | +6

CommentOn: Aliment Pharmacol Ther. 2012 Oct;36(8):765-71. - PMID 22928581

4

Commentary : BMI and the need for adalimumab dose escalation in Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2012

von Van Assche, G. | Baert, F. | Vermeire, S.

CommentOn: Aliment Pharmacol Ther. 2012 Feb;35(3):335-41. - PMID 22191671

5

Early serial trough and antidrug antibody level measurements predict clinical outcome of infliximab and adalimumab treatment

enthalten in: Gut | 2012

von Vande Casteele, N. | Ballet, V. | Van Assche, G. | +3

CommentOn: Gut. 2011 Jan;60(1):41-8. - PMID 20519742

6

Incidence of acute severe infusion reactions to infliximab depends on definition used rather than assay

enthalten in: Alimentary pharmacology & therapeutics | 2011

von Vande Casteele, N. | Breynaert, C. | Vermeire, S. | +3

CommentOn: Aliment Pharmacol Ther. 2011 Jul;34(1):51-8. - PMID 21535447

7

The Dutch guidelines for treatment with infliximab for Crohn's disease

enthalten in: The Netherlands journal of medicine | 2006

von Vermeire, S.

CommentIn: Neth J Med. 2006 Jul-Aug;64(7):212-8. - PMID 16929082

8

Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae (ASCA) in patients with Crohn's disease

enthalten in: Gut | 2006

von Joossens, S. | Pierik, M. | Rector, A. | +4

CommentOn: Gut. 2005 Oct;54(10):1370-6. - PMID 15972301

9

The use of immunosuppressive drugs in IBD : RAND or random choice?

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2005

von Vermeire, S.

CommentOn: Dig Liver Dis. 2005 Jun;37(6):407-17. - PMID 15893279

10

RE : Development of an assay for antibodies to Saccharomyces cerevisiae: Easy, cheap and specific for Crohn's disease

enthalten in: Canadian journal of gastroenterology = Journal canadien de gastroenterologie | 2001

von Vermeire, S. | Wild, G.

CommentOn: Can J Gastroenterol. 2001 Aug;15(8):499-504. - PMID 11544532